Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM2SALJ)

Drug Name
Flanvotumab Drug Info
Synonyms IMC-20D7S; Gp75 monoclonal antibodies (melanoma), ImClone; Gp75 mAb (melanoma), ImClone/Eli Lilly; GP75/TRP1 mAbs (melanoma), ImClone/Eli Lilly
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM2SALJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Melanoma antigen gp75 (TYRP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
FLX-787 DMQX5UA Amyotrophic lateral sclerosis 8B60.0 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Melanoma antigen gp75 (TYRP1) TTFRV98 TYRP1_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT01137006) An Open-Label, Dose-Escalation Study of IMC-20D7S In Patients With Malignant Melanoma. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 675217).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)